Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $74.21 -0.27%
Revenue Growth %: +89.6%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +89.6%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.41, $0.44 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $151.81 million versus the consensus estimate of $112.72 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
